Literature DB >> 2839503

The structure of the human skin fibroblast collagenase gene.

I E Collier1, J Smith, A Kronberger, E A Bauer, S M Wilhelm, A Z Eisen, G I Goldberg.   

Abstract

Genomic clones containing the complete gene encoding human fibroblast interstitial collagenase were isolated from a lambda phage human DNA library. The gene is comprised from 10 exons and spans 8.2 kilobase pairs. We have mapped the relative positions and determined the DNA sequence of all the exon/intron borders of the gene. The organization of the human interstitial collagenase gene is very similar to that of rabbit collagenase and of two other extracellular matrix (ECM) metalloproteases: rat stromelysin (transin) and rat transin 2. All four genes are organized into 10 exons of virtually identical size while the length of the 3' proximal introns is subject to variation. The protein sequence comprising the putative active center is coded for by exon 5 of all four genes and contains a strongly conserved zinc binding site. This observation suggests that the organization of the ECM metalloprotease genes reflect the structure of the functional domains of the enzyme proteins. The structural data accumulated so far provides evidence for the existence of a gene family coding for secreted ECM metalloproteases and suggests that gene duplication played an important role in its formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839503

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

Authors:  H G Welgus; E J Campbell; J D Cury; A Z Eisen; R M Senior; S M Wilhelm; G I Goldberg
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.

Authors:  M Shindoh; F Higashino; M Kaya; M Yasuda; K Funaoka; M Hanzawa; K Hida; T Kohgo; A Amemiya; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.

Authors:  C S HE; S M Wilhelm; A P Pentland; B L Marmer; G A Grant; A Z Eisen; G I Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.

Authors:  T Yoshizaki; H Sato; M Furukawa; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Thyroid hormone-dependent expression of bullfrog tadpole collagenase gene.

Authors:  Ken Oofusa; Katsutoshi Yoshizato
Journal:  Rouxs Arch Dev Biol       Date:  1996-02

6.  Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia.

Authors:  M Colombi; R Gardella; N Zoppi; L Moro; D Marini; N K Spurr; S Barlati
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

7.  Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype.

Authors:  A Hovnanian; P Duquesnoy; S Amselem; C Blanchet-Bardon; M Lathrop; L Dubertret; M Goossens
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Unique organization and involvement of GAGA factors in transcriptional regulation of the Xenopus stromelysin-3 gene.

Authors:  J Li; V C Liang; T Sedgwick; J Wong; Y B Shi
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

9.  Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.

Authors:  I Shima; Y Sasaguri; J Kusukawa; R Nakano; H Yamana; H Fujita; T Kakegawa; M Morimatsu
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.